Medbiome’s founders demonstrated that structurally similar compounds can have distinct effects on individual microbiomes

In a recent paper in Gut Microbes the founders of MedBiome reported the effects of berberine (BBR) and 16 structural analogs on seven individual gut microbiomes using our RapidAIM technology. This article clearly illustrates that the RapidAIM technology can distinguish the effects of structurally similar compounds on individual microbiomes. This is an important milestone when selecting and optimizing compounds to target the gut microbiome.